Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.48 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.43 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 5/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759815 | 0.99 | PLA2G2A (0.50) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6763908 | 0.96 | MEN1 (0.48) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6764160 | 0.88 | RECQL (0.45) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6766244 | 0.87 | PLA2G2A (0.46) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6761532 | 0.86 | NR4A1 (0.48) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6762804 | 0.86 | PLA2G2A (0.48) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6762452 | 0.85 | TSHR (0.45) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6761449 | 0.85 | NR4A1 (0.50) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6761346 | 0.85 | FFAR1 (0.44) | PLA2G2APLA2G5FFAR1MEN1KMT2A | |
| SCHEMBL6759787 | 0.85 | NR4A1 (0.45) | PLA2G2APLA2G5FFAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040247698-A1 | Erectile Dysfunction Treatment | VALENZUELA CORTES CARMEN MARIA (CL) | 2004-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040247698-A1 | Erectile Dysfunction Treatment | PDE3A, PDE3B, PDE12 | PLA2G2A 2273/4885PLA2G5 1820/4885FFAR1 2283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.